Pathway Health Announces Research Collaboration with Tilray

Published: February 18, 2021

Pathway Health Announces Research Collaboration with Tilray

Pathway Health, Corp. announced a research collaboration with Tilray Canada Ltd, a subsidiary of Tilray, Inc., one of the world’s leading companies in the research, manufacture and distribution of medicinal cannabis.  The Medical Cannabis in Older Patients Study (MCOPS) is a 6-month observational study sponsored by Tilray that will examine the impact of medical cannabis on chronic pain, sleep, quality of life, and prescription medication use in patients older than 50 years of age.

Pathway’s Chief Commercial Officer, Kim Wei, commented, “Pathway Health is pleased to be working with Tilray on this important study which we believe will advance our knowledge on the potential benefits of medical cannabis for all or certain of these medical conditions.”

Philippe Lucas, VP of Global Patient Research and Access at Tilray, adds that, “older individuals are amongst the fastest growing group of medical cannabis patients in Canada and around the world. Prospective, multi-site studies like MCOPS can improve the understanding of how older patients currently use medical cannabis, and its potential harms and benefits in this unique population.”

Pathway Health is one of the largest providers of out-of-hospital pain management services in Canada.  The Company owns and operates 9 community-based clinics across 4 provinces where its team of health professionals work together to help patients through a variety of evidence-based approaches.  Pathway Health’s patient care programs utilize an interdisciplinary approach that is guided by trained pain specialists, physical and occupational therapists, psychologists, nurses and other healthcare providers.  Pathway Health has also developed an expertise in harm reduction where medicinal cannabis is being used as an alternative to traditional opioids.

For more information, visit Pathway Health’s website:

Recent News

View All News Items

Latest Article

High Spirits and Higher Sales: Cannabis Seen as a Staple During the Holidays

High Spirits and Higher Sales: Cannabis Seen as a Staple During the Holidays

As the holiday season approaches, consumers across Canada are gearing up for festivities and gift-giving. While traditional retail industries have long capitalized on holiday consumer spending habits, the cannabis market is quickly establishing itself as a key player in this annual economic surge.

Read Article